Jump to ContentJump to Main Navigation
Show Summary Details
More options …

The Journal of Critical Care Medicine

4 Issues per year

Open Access
Online
ISSN
2393-1817
See all formats and pricing
More options …

Anemia in Intensive Care: A review of Current Concepts

Gautam Rawal
  • Corresponding author
  • Respiratory Intensive Care, Max Super Specialty Hospital, Saket, New Delhi, India
  • Flat No. 417, Dhruva Apartments, Plot no. 4, I P Extension, Patparganj, Delhi, India, Pin-110092.
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Raj Kumar / Sankalp Yadav / Amrita Singh
Published Online: 2016-08-10 | DOI: https://doi.org/10.1515/jccm-2016-0017

Abstract

Anemia in patients admitted to an intensive care unit is common and affects almost all critically ill patients. The intensivist is faced with the challenge of treating multifactorial etiologies, mainly bleeding and blood loss due to phlebotomy and decreased erythropoiesis. Red cell transfusion, the most common treatment for anemia, comes with associated risks, which may further reduce the chance of survival of these patients. The best evidence suggests the practice of restrictive RBC transfusion (transfusion at Hb<7 g/dl).

In this article, the etiopathogenesis of the anemia in critically ill is reviewed, and current opinion on the pros and cons of various management strategies are discussed with emphasize on restrictive transfusion policy.

Keywords: anemia; critical illness; erythropoietin; intensive care; red blood cell; transfusion

References

  • 1. Astin R, Puthucheary Z. Anaemia secondary to critical illness: an unexplained phenomenon. Extrem Physiol Med. 2014;3:4.CrossrefGoogle Scholar

  • 2. Thomas J, Jensen L, Nahirniak S, Gibney RT. Anemia and blood transfusion practices in the critically ill: a prospective cohort review. Heart Lung. 2010;39:217-25.Web of ScienceCrossrefGoogle Scholar

  • 3. Hajjar LA, Auler Junior JO, Santos L, Galas F. Blood tranfusion in critically ill patients: state of the art. Clinics (Sao Paulo). 2007;62:507-24.CrossrefGoogle Scholar

  • 4. Athar MK, Puri N, Gerber DR. Anemia and Blood Transfusions in Critically Ill Patients. Journal of blood transfusion. 2012;2012:629204.Google Scholar

  • 5. McEvoy MT, Shander A. Anemia, bleeding, and blood transfusion in the intensive care unit: Causes, risks, costs, and new strategies. Am J Crit Care. 2013;22:eS1-13.CrossrefWeb of ScienceGoogle Scholar

  • 6. Chant C, Wilson G, Friedrich JO. Anemia, transfusion, and phlebotomy practices in critically ill patients with prolonged ICU length of stay: a cohort study. Crit Care. 2006;10:R140.CrossrefGoogle Scholar

  • 7. Harber CR, Sosnowski KJ, Hegde RM. Highly conservative phlebotomy in adult intensive care-a prospective randomized controlled trial. Anaesth Intensive Care. 2006;34:434-7.Google Scholar

  • 8. Arnold DM, Donahoe L, Clarke FJ, et al. Bleeding during critical illness: a prospective cohort study using a new measurement tool. Clin Invest Med. 2007;30:E93-E102.Google Scholar

  • 9. Greinacher A, Selleng K. Thrombocytopenia in the intensive care unit patient. Hematology Am Soc Hematol Educ Program. 2010;2010:135-43.Google Scholar

  • 10. Marks PW. Coagulation disorders in the ICU. Clin Chest Med. 2009;30:123-9.CrossrefGoogle Scholar

  • 11. Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol. 2009;145:24-33.CrossrefGoogle Scholar

  • 12. Cook D, Heyland D, Griffith L, Cook R, Marshall J, Pagliarello J. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation Canadian Critical Care Trials Group. Crit Care Med. 1999;27:2812-7.CrossrefGoogle Scholar

  • 13. Jelkmann I, Jelkmann W. Impact of Erythropoietin on Intensive Care Unit Patients. Transfus Med Hemother. 2013;40:310-8.CrossrefGoogle Scholar

  • 14. Rodriguez RM, Corwin HL, Gettinger A, Corwin MJ, Gubler D, Pearl RG. Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care. 2001;16:36-41.CrossrefGoogle Scholar

  • 15. Woodman R, Ferrucci L, Guralnik J. Anemia in older adults. Curr Opin Hematol. 2005;12:123-8.Google Scholar

  • 16. Lasocki S, Longrois D, Montravers P, Beaumont C. Hepcidin and anemia of the critically ill patient: bench to bedside. Anesthesiology. 2011;114:688-94.Web of ScienceCrossrefGoogle Scholar

  • 17. Goodnough LT. Iron deficiency syndromes and iron-restricted erythropoiesis (CME). Transfusion. 2012;52:1584-92.CrossrefWeb of ScienceGoogle Scholar

  • 18. Ganz T, Nemeth E. The hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disorders. Hematology Am Soc Hematol Educ Program. 2011;2011:538-42.Google Scholar

  • 19. Fernandez R, Tubau I, Masip J, Munoz L, Roig I, Artigas A. Low reticulocyte hemoglobin content is associated with a higher blood transfusion rate in critically ill patients: a cohort study. Anesthesiology. 2010;112:1211-5.CrossrefWeb of ScienceGoogle Scholar

  • 20. Patteril MV, Davey-Quinn AP, Gedney JA, Murdoch SD, Bellamy MC. Functional iron deficiency, infection and systemic inflammatory response syndrome in critical illness. Anaesth Intensive Care. 2001;29:473-8.Google Scholar

  • 21. Bellamy MC, Gedney JA. Unrecognised iron deficiency in critical illness. Lancet. 1998;352(9144):1903.Google Scholar

  • 22. Garratty G. Immune hemolytic anemia caused by drugs. Expert Opin Drug Saf. 2012;11: 635-42.CrossrefWeb of ScienceGoogle Scholar

  • 23. Hayden SJ, Albert TJ, Watkins TR, Swenson ER. Anemia in critical illness: insights into etiology, consequences, and management. Am J Respir Crit Care Med. 2012;185:1049-57.Web of ScienceGoogle Scholar

  • 24. De Souza DA, Silva FG e, Costa PJM de S. Critical evaluation of justifications for the transfusion of red blood cells: the reality of a government emergency hospital. Rev Bras Hematol Hemoter. 2013;35:263-7.CrossrefGoogle Scholar

  • 25. Sihler KC, Napolitano LM. Complications of massive transfusion. Chest. 2010;137:209-20.CrossrefWeb of ScienceGoogle Scholar

  • 26. Toy P, Gajic O, Bacchetti P, et al. Transfusion-related acute lung injury: incidence and risk factors. Blood. 2012;119:1757-67.Web of ScienceCrossrefGoogle Scholar

  • 27. Vlaar AP, Hofstra JJ, Determann RM, et al. The incidence, risk factors, and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery patients: a prospective nested casecontrol study. Blood. 2011;117:4218-25.CrossrefGoogle Scholar

  • 28. Narick C, Triulzi DJ, Yazer MH. Transfusion-associated circulatory overload after plasma transfusion. Transfusion. 2012;52:160-5.CrossrefWeb of ScienceGoogle Scholar

  • 29. Li G, Rachmale S, Kojicic M, et al. Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients. Transfusion. 2011;51:338-43.CrossrefWeb of ScienceGoogle Scholar

  • 30. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev. 2007;21:327-48.CrossrefGoogle Scholar

  • 31. Salpeter SR, Buckley JS, Chatterjee S. Impact of more restrictive blood transfusion strategies on clinical outcomes: a metaanalysis and systematic review. Am J Med. 2014;127:124-31.CrossrefGoogle Scholar

  • 32. Stubbs JR. Alternatives to blood product transfusion in the critically ill: erythropoietin. Crit Care Med. 2006;34:S160-9.CrossrefGoogle Scholar

  • 33. Corwin HL. The role of erythropoietin therapy in the critically ill. Transfus Med Rev. 2006;20:27-33.CrossrefGoogle Scholar

  • 34. Jelkmann I, Jelkmann W. Impact of Erythropoietin on Intensive Care Unit Patients. Transfus Med Hemother. 2013;40:310-8.CrossrefGoogle Scholar

  • 35. Moore EE, Moore FA, Fabian TC, et al. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial. J Am Coll Surg. 2009;208:1-13.CrossrefWeb of ScienceGoogle Scholar

  • 36. Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA. 2008;299:2304-12.Web of ScienceGoogle Scholar

  • 37. Jahr JS, Mackenzie C, Pearce LB, Pitman A, Greenburg AG. HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery. J Trauma. 2008;64:1484-97.CrossrefWeb of ScienceGoogle Scholar

  • 38. Khan FA, Fisher MA, Khakoo RA. Association of hemochromatosis with infectious diseases: expanding spectrum. Int J Infect Dis. 2007;11:482-7.Web of ScienceCrossrefGoogle Scholar

  • 39. Weinberg ED. Iron loading and disease surveillance. Emerg Infect Dis. 1999;5:346-52. CrossrefGoogle Scholar

About the article

Received: 2016-05-05

Accepted: 2016-06-29

Published Online: 2016-08-10

Published in Print: 2016-07-01


Citation Information: The Journal of Critical Care Medicine, ISSN (Online) 2393-1817, DOI: https://doi.org/10.1515/jccm-2016-0017.

Export Citation

© 2016. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License. BY-NC-ND 4.0

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Ecaterina Scarlatescu, Dana Tomescu, and Sorin Stefan Arama
The Journal of Critical Care Medicine, 2016, Volume 2, Number 4

Comments (0)

Please log in or register to comment.
Log in